Compass Pathways dropped their Phase 3 results for Pseudocybin.
🌈 The PR says it’s a win.
🔬 The data says... meh.
📉 The market says nope.
The DOPE DEALER dug in. youtu.be/V9-pqSyQdVI
#PsychedelicScience #DataNotHype #DepressionResearch #BigPharmaWatch
🌈 The PR says it’s a win.
🔬 The data says... meh.
📉 The market says nope.
The DOPE DEALER dug in. youtu.be/V9-pqSyQdVI
#PsychedelicScience #DataNotHype #DepressionResearch #BigPharmaWatch
Did Mushrooms Really Beat Depression This Time?
Compass Pathways, makers of Comp360 synthetic psilocybin, have finished their Phase III human trial for Treatment Resistant Depression. In this video, we'll dive into the latest research on how psilocybin fared in helping individuals who have struggled with depression, despite trying various treatme
youtu.be
July 16, 2025 at 3:38 PM
Compass Pathways dropped their Phase 3 results for Pseudocybin.
🌈 The PR says it’s a win.
🔬 The data says... meh.
📉 The market says nope.
The DOPE DEALER dug in. youtu.be/V9-pqSyQdVI
#PsychedelicScience #DataNotHype #DepressionResearch #BigPharmaWatch
🌈 The PR says it’s a win.
🔬 The data says... meh.
📉 The market says nope.
The DOPE DEALER dug in. youtu.be/V9-pqSyQdVI
#PsychedelicScience #DataNotHype #DepressionResearch #BigPharmaWatch